Alnylam Pharmaceuticals
ALNY
#640
Rank
$31.30 B
Marketcap
$242.74
Share price
-5.89%
Change (1 day)
42.80%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Net assets

Net assets on the balance sheet as of September 2024 : $32.35 Million USD

According to Alnylam Pharmaceuticals 's latest financial reports the company has $32.35 Million USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alnylam Pharmaceuticals - Net assets on balance sheet (from 2003 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$-$0.23 Billion39.45%
2022-12-31$-$0.16 Billion-126.9%
2021-12-31$$0.58 B-42.12%
2020-12-31$$1.01 B-29.36%
2019-12-31$$1.43 B10.5%
2018-12-31$$1.30 B-26.29%
2017-12-31$$1.76 B91.96%
2016-12-31$$0.92 B-27.24%
2015-12-31$$1.26 B35.08%
2014-12-31$$0.93 B246.32%
2013-12-31$$0.27 B101.67%
2012-12-31$$0.13 B13.61%
2011-12-31$$0.11 B-25.43%
2010-12-31$$0.15 B-11.09%
2009-12-31$$0.17 B-11.95%
2008-12-31$$0.20 B1.48%
2007-12-31$$0.19 B-1%
2006-12-31$$0.20 B225.63%
2005-12-31$$61.77 M33.89%
2004-12-31$$46.14 M-272.77%
2003-12-31$-$26.71 Million474.84%
2002-12-31$-$4.65 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
$0.33 B 947.70%๐Ÿ‡บ๐Ÿ‡ธ USA
$29.32 B 90,540.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.22 B 3,674.09%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.39 B 4,212.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$98.18 M 203.46%๐Ÿ‡บ๐Ÿ‡ธ USA
$43.44 B 134,167.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$78.25 B 241,760.67%๐Ÿ‡ซ๐Ÿ‡ท France
$6.38 B 19,631.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel